BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30829123)

  • 1. A modified Wald test for reference scaled assessment of analytical equivalence.
    Weng YT; Tsong Y; Shen M; Wang C
    J Biopharm Stat; 2019; 29(6):1068-1081. PubMed ID: 30829123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wald tests for variance-adjusted equivalence assessment with normal endpoints.
    Chen YM; Weng YT; Dong X; Tsong Y
    J Biopharm Stat; 2017; 27(2):308-316. PubMed ID: 27906607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exact test-based approach for equivalence test with parameter margin.
    Cassie Dong X; Bian Y; Tsong Y; Wang T
    J Biopharm Stat; 2017; 27(2):317-330. PubMed ID: 28055327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inference of equivalence for the ratio of two normal means with unspecified variances.
    Xu S; Hua SY; Menton R; Barker K; Menon S; D'Agostino RB
    J Biopharm Stat; 2014; 24(6):1264-79. PubMed ID: 25033269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equivalence assessment for interchangeability based on two-sided tests.
    Dong X; Tsong Y
    J Biopharm Stat; 2014; 24(6):1312-31. PubMed ID: 25032976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equivalence tests for interchangeability based on two one-sided probabilities.
    Dong X; Tsong Y; Shen M
    J Biopharm Stat; 2014; 24(6):1332-48. PubMed ID: 25033074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On tests of equivalence via non-unity relative risk for matched-pair design.
    Tang NS; Tang ML; Chan IS
    Stat Med; 2003 Apr; 22(8):1217-33. PubMed ID: 12687652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model-based analyses of bioequivalence crossover trials using the stochastic approximation expectation maximisation algorithm.
    Dubois A; Lavielle M; Gsteiger S; Pigeolet E; Mentré F
    Stat Med; 2011 Sep; 30(21):2582-600. PubMed ID: 21793036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tests for equivalence or non-inferiority for paired binary data.
    Liu JP; Hsueh HM; Hsieh E; Chen JJ
    Stat Med; 2002 Jan; 21(2):231-45. PubMed ID: 11782062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Test Statistics and Confidence Intervals to Establish Noninferiority between Treatments with Ordinal Categorical Data.
    Zhang F; Miyaoka E; Huang F; Tanaka Y
    J Biopharm Stat; 2015; 25(5):921-38. PubMed ID: 24919157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample size determination for equivalence assessment with multiple endpoints.
    Sun A; Dong X; Tsong Y
    J Biopharm Stat; 2014; 24(6):1203-14. PubMed ID: 25032845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
    Lui KJ; Chang KC
    Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tests for equivalence based on odds ratio for matched-pair design.
    Liu JP; Fan HY; Ma MC
    J Biopharm Stat; 2005; 15(6):889-901. PubMed ID: 16279349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On Statistical Approaches for Demonstrating Analytical Similarity in the Presence of Correlation.
    Yang H; Novick S; Burdick RK
    PDA J Pharm Sci Technol; 2016 11/12; 70(6):547-559. PubMed ID: 27325594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample size determination for matched-pair equivalence trials using rate ratio.
    Tang NS; Tang ML; Wang SF
    Biostatistics; 2007 Jul; 8(3):625-31. PubMed ID: 17071862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation by simulation of tests based on non-linear mixed-effects models in pharmacokinetic interaction and bioequivalence cross-over trials.
    Panhard X; Mentré F
    Stat Med; 2005 May; 24(10):1509-24. PubMed ID: 15761916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An approximate approach to sampling size determination for the equivalence hypothesis.
    Hsieh CY; Liu JP
    J Biopharm Stat; 2013 May; 23(3):526-38. PubMed ID: 23611193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of profile-likelihood-based confidence intervals with other rank-based methods for the two-sample problem in ordered categorical data.
    Funatogawa I; Funatogawa T
    J Biopharm Stat; 2023 May; 33(3):371-385. PubMed ID: 36533908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and analysis of three-arm trials with negative binomially distributed endpoints.
    Mütze T; Munk A; Friede T
    Stat Med; 2016 Feb; 35(4):505-21. PubMed ID: 26388314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Wald test comparing medical costs based on log-normal distributions with zero valued costs.
    Tu W; Zhou XH
    Stat Med; 1999 Oct; 18(20):2749-61. PubMed ID: 10521864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.